Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Role of long non-coding RNAs in adipose tissue metabolism and associated pathologies

  • Corral, Ana
  • Alcalá, Martin
  • Durán Ruiz, María del Carmen
  • Arroba Espinosa, Ana Isabel
  • Ponce González, Jesús Gustavo
  • Todorčević, Marijana
  • Serra, Dolors
  • Calderón Domínguez, María
  • Herrero, Laura
The incidence of obesity and its related disorders has increased dramatically in recent years and has become a pandemic. Adipose tissue is a crucial regulator of these diseases due to its endocrine capacity. Thus, understanding adipose tissue metabolism is essential to finding new effective therapeutic approaches. The "omic" revolution has identified new concepts about the complexity of the signaling pathways involved in the pathophysiology of adipose tissue-associated disorders. Specifically, advances in transcriptomics have allowed its application in clinical practice and primary or secondary prevention. Long non-coding RNAs (lncRNAs) have emerged as critical regulators of adipose tissue since they can modulate gene expression at the epigenetic, transcriptional, and post-transcriptional levels. They interact with DNA, RNA, protein complexes, other noncoding RNAs, and microRNAs to regulate a wide range of physiological and pathological processes. Here, we review the emerging field of lncRNAs, including how they regulate adipose tissue biology, and discuss circulating lncRNAs, which may represent a turning point in the diagnosis and treatment of adipose tissue-associated disorders. We also highlight potential biomarkers of obesity and diabetes that could be considered as therapeutic targets., This study was supported by the Spanish Ministry of Science and Innovation (MCIN) (PID2020-114953RB-C21 to LH and DS, co-funded by the European Regional Development Fund [ERDF], PID2020-114343GA-100 to MA, and PID2019-110063RA-I00 to JP and MC), the Biomedical Research Centre in Pathophysiology of Obesity and Nutrition (CIBEROBN) (Grant CB06/03/0001 to LH), and the Merck Health Foundation (to LH). AC is a recipient of the Formación de Personal Investigador (FPI) doctoral fellowship from the MCIN.‬‬‬‬‬‬ We thank MCarmen Soler-Vázquez for her expert assistance in the preparation of Fig. 1 .
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

  • González-Franquesa, A.
  • Gama-Pérez, P.
  • Kulis, M.
  • Szczepanowska, K.
  • Dahdah, N.
  • Moreno-Gómez, S.
  • Latorre Pellicer, A.
  • Fernández-Ruiz, R.
  • Aguilar-Mogas, A.
  • Hoffman, A.
  • Monelli, E.
  • Samino, S.
  • Miró-Blanch, J.
  • Oemer, G.
  • Duran, X.
  • Sánchez-Rebordelo, E.
  • Schneeberger, M.
  • Obach, M.
  • Montane, J.
  • Castellano, G.
  • Chapaprieta, V.
  • Sun, W.
  • Navarro, L.
  • Prieto, I.
  • Castaño, C.
  • Novials, A.
  • Gomis, R.
  • Monsalve, M.
  • Claret, M.
  • Graupera, M.
  • Soria, G.
  • Wolfrum, C.
  • Vendrell, J.
  • Fernández-Veledo, S.
  • Enríquez, J. A.
  • Carracedo, A.
  • Perales, J. C.
  • Nogueiras, R.
  • Herrero, L.
  • Trifunovic, A.
  • Keller, M. A.
  • Yanes, O.
  • Sales-Pardo, M.
  • Guimerà, R.
  • Blüher, M.
  • Martín-Subero, J. I.
  • García-Roves, P.
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue.